Given these findings, and our previous results demonstrating that elevated IFNγ-R1 levels sensitize tumor cells to IFNγ treatment and cytotoxic T cells, we next tested whether STUB1 inactivation induces hypersensitivity to (T cell-derived) IFNγ. The gene discussed is IFNG; the disease is neoplasm.